Yi Shijian

Yi Shijian Professor and Chief Physician

SZU General Hospital

Professor and Chief Physician

General Surgery


BIOGRAPHICAL SKETCH


NAME: Yi Shijian


POSITION TITLE: Professor, Chief Physician


EDUCATION/TRAINING

INSTITUTION AND LOCATION

DEGREE

COMLETION DATE

FIELD OF STUDY

Hengyang School of Medical, University of South China

B.D.

1993

Clinical Medicine

Xiangya School of Medical, Central South University

M.D.

2005

Surgery

?

?

?

?

?

?

?

?

?

?

?

?

?

A. Personal statement

Yi Shijian is a Member of the Communist Party of China, Chief Physician of General Surgery, Professor of Surgery, Supervisor of Postgraduates, and Cooperative Supervisor. Yi Shijian is the Secretary of the General Party Branch of the Outpatient Department of Shenzhen University General Hospital and Director of the Outpatient Department. He is a Senior Visiting Scholar at the KECK Medical Center, University of Southern California, and Head of the Shenzhen Base, Institute of Minimally Invasive Surgery, Jinan University. Yi Shijian is the former Director of General Surgery and Director of Minimally Invasive Surgery for >10 years. He is Vice Chairman of the World Endoscopy Physicians Association Branch of Natural Endocrinology Doctors; Vice Chairman of the Endoscopy Mini-invasive Bile Protection Committee of the Endoscopy Physicians Branch of the Chinese Medical Doctor Association Chairman; a member of the Standing Committee of the General Association of General Microinjury and Endoscopy of the Chinese Association of World Endoscopy Physicians; the National Deputy Leader of the Disaster and Trauma Treatment Expert Group of the Chinese Society of Integrated Chinese and Western Medicine; Director of the Breast Specialist Branch of Guangdong Medical Association; Deputy Chairman of the Thyroid and Breast Surgery Special Committee of Shenzhen Medical Association; and Vice President of the Hernia and Abdominal Surgery Branch of Shenzhen Medical Association. He is an Editorial Board Member of the "Chinese Journal of Endoscopy", the "Chinese Electronic Journal of Obesity and Metabolic Diseases" and "Chinese Medical Engineering".

His main engagements are in minimally invasive general surgery, clinical medicine, scientific research and teaching. He has expertise in precise individualized comprehensive treatment of thyroid and breast tumors; microscopic clinical-applied anatomy research of recurrent laryngeal nerve under endoscopy; endoscopic thyroid surgery of the recurrent laryngeal nerve; the parathyroid protection strategy; development and application of micro-device platforms for thyroid robotic surgery systems; quality of life care; recurrence and survival analysis of breast-conserving breast cancers; gene sequencing of breast cancers; sequencing of CTC single cells; and intra-abdominal pressure and inguinal hernia formation .

He has participated in two projects of the National Natural Science Foundation of China, has presided over and completed one project of the Hunan Science and Technology Plan, guided and completed five projects of the Shenzhen Science and Technology Plan, and performed research for one project of the Shenzhen Knowledge Innovation Plan.

?

B. Positions and honors

Positions

2005-2016: Professor, Chief Physician, Department of General Surgery Shenzhen Fuyong People's Hospital.

2016-preset: Professor, Chief Physician, Department of General Surgery, Shenzhen University General Hospital; and Director of the Outpatient Department of Shenzhen University General Hospital.

?

Honors

2016 Award for Science and Technology, Jiangsu Province, 3rd position

2016 Advanced Worker of Shenzhen University Medical Department

2019 Outstanding manager of Shenzhen University General Hospital

C. Representative publications (selected publications in recent five years ? 5-10篇)

1. Shijian Yi , Guowen Liu , Yang Wu , Qiankun Liang , Lanlan Li..Biacalein suppresses the growth of the human thyroid cancer cells by inducing mitotic catastrophe, apoptosis and autophagy via NF-kB signalling pathway[J]. J BUON,?2020;?25(1):389-394.

2. Ting He, Han Xu, Yifan Zhang, Shijian Yi, Run Cui, Shaojun Xing1, Chaoliang Wei, Jing Lin, PengHuang. Glucose oxidase-instructed traceable self-oxygenation/hyperthermia dually enhanced cancer starvation therapy[J]. Theranostics 2020; 10(4):2413-2422.

3.?S.J.Yi,?L.L.?Li,?W.B.Tu.?MiR-214 negatively regulates proliferation and WNT/β-catenin signaling in breast cancer[J].?European Review for Medical and Pharmacological Sciences,?2016,?20(24):5148-5154.

4. WU Yang,YI Shijian .Clinical analysis of transumbilical single?incision laparoscopic radical resection of colon cancer[J]. Medical Science Journal of Central South China,?2017,?50(5):851-852.

5.Tu Wenbin, YI Shijian, Zhao Zhenwei, Wang Xingqun, Zhan Chaoyan,Wu Yang.?The superiority of interventional embolization technique in the treatment of traumatic rupture of the liver and spleen hemorrhage[J].?Chin J Hygiene Rescue?(Eletronic Edition),?2016,?(5):306-309.

6.Shi-jian YI, Wen-bin TU, Yang WU, Ke-wan LI.?Clinical analysis of laparoscopic totally extraperitoneal hernia repair combined with high position ligation of spermatic vein[J].?Chinese Journal of Endoscopy,?2016,?22(12):100-102.

7.?Yi Shijian, Wu Yang, Tu Wenbin.?Clinical application of 3D laparoscopic approach in the buccal cavity through thyroid surgery[J]. Medical Science Journal of Central South China, 2016,?44(6):651-652.

8. Wu Yang, Yi Shijian, Wand Cunchuan. The effect of endoscopic thyroidectomy through transoral [J].Medical Science Journal of Central South China, 2015, 43(6): 627-631.

?

D. Research support

1.Chinese National Natural Science Foundation: MRI diffusion imaging of transcatheter arterial chemoembolization for liver cancer. (No. 30070235)

2.?Hunan Science and Technology Plan Project:?Study on the mechanism of alpha-fetoprotein in promoting the growth of liver cancer cells. (No. 05SK3023)

3.?Basic research project of Shenzhen Science and Technology Innovation Committee:?Experimental study of compound amino acid combined with high-dose vitamin B6 in the treatment of traumatic coagulopathy. (No. JCYJ20170818102312352)

4.?Basic research project of Shenzhen Science and Technology Innovation Committee:?Clinical study of intra-abdominal pressure in patients with indirect inguinal hernia.?(No. 201003146)

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?

×

用户登录